Related Experiment Video
Updated: Jun 25, 2026
Real-time Analyses of Retinol Transport by the Membrane Receptor of Plasma Retinol Binding Protein
Published on: January 28, 2013
Preliminary report: Serum levels of retinol-binding protein 4 in preeclampsia
Holger Stepan1, Thomas Ebert, Susanne Schrey
1Department of Obstetrics, University of Leipzig, Leipzig 04103, Germany.
Insights
Serum levels of retinol-binding protein 4 (RBP4) were similar in preeclampsia patients and healthy controls. This study found no significant association between RBP4 and preeclampsia, suggesting it does not play a role in the condition's development.
Area of Science:
- Reproductive biology
- Endocrinology
- Metabolic disease
Background:
- Preeclampsia (PE) is a serious pregnancy complication.
- Adipokines, like retinol-binding protein 4 (RBP4), are implicated in metabolic and cardiovascular health.
- The role of RBP4 in PE pathogenesis remains unclear.
Purpose of the Study:
- To investigate serum levels of retinol-binding protein 4 (RBP4) in patients with preeclampsia (PE).
- To compare RBP4 levels in PE patients versus healthy pregnant controls.
- To explore the correlation between RBP4 and clinical outcomes in PE.
Main Methods:
- Serum RBP4 concentrations were measured using enzyme-linked immunosorbent assay (ELISA).
- Study included 16 patients with PE and 20 healthy pregnant controls.
- Correlations with clinical and biochemical parameters were analyzed.
Main Results:
- Mean maternal RBP4 concentrations were not significantly different between PE patients (24.5 mg/L) and controls (22.3 mg/L).
- RBP4 levels did not correlate with pregnancy outcomes, renal function, glucose/lipid metabolism, or inflammation markers.
- No statistically significant association was found between RBP4 and PE.
Conclusions:
- The findings do not support a role for RBP4 in the pathogenesis of preeclampsia.
- Further research may be needed to fully elucidate the role of adipokines in PE.
- RBP4 is unlikely to be a significant factor in PE development based on this study.
Abstract:
The objective of the study was to investigate serum levels of the adipokine retinol-binding protein 4 (RBP4) in patients with preeclampsia (PE) as compared with healthy controls of similar gestational age. Retinol-binding protein 4 serum levels were quantified by enzyme-linked immunosorbent assay in control (n = 20) and PE (n = 16) patients. Mean maternal RBP4 concentrations were not significantly different in PE (24.5 mg/L) as compared with controls (22.3 mg/L). Furthermore, RBP4 did not correlate to clinical and biochemical measures of pregnancy outcome, renal function, glucose, and lipid metabolism, as well as inflammation. Our results do not support a role of RBP4 in the pathogenesis of PE.
